Consolidated BRCA1/2 Variant Interpretation by MH BRCA Correlates with Predicted PARP Inhibitor Efficacy Association by MH Guide

机译：MH对BRCA1 / 2变体的综合解释与MH Guide预测的PARP抑制剂功效协会相关

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

期刊名称 International Journal of Molecular Sciences
作者
Yosuke Hirotsu; Udo Schmidt-Edelkraut; Hiroshi Nakagomi; Ikuko Sakamoto; Markus Hartenfeller; Ram Narang; Theodoros G. Soldatos; Sajo Kaduthanam; Xiaoyue Wang; Stephan Hettich; Stephan Brock; David B. Jackson; Masao Omata;
展开▼
作者单位

展开▼
年(卷),期 2020(21),11
年度 2020
页码 -1
总页数 13
原文格式 PDF
正文语种
中图分类分子生物学;
关键词

相似文献

外文文献
中文文献
专利

1. Efficacy of the PARP Inhibitor Veliparib with Carboplatin or as a Single Agent in Patients with Germline BRCA1- or BRCA2-Associated Metastatic Breast Cancer: California Cancer Consortium Trial NCT01149083 [J] . Somlo George, Frankel Paul H., Arun Banu K., Clinical cancer research: an official journal of the American Association for Cancer Research . 2017,第15期

机译：PARP抑制剂Veliparib与Carboplatin的疗效或作为种系BRCA1-或BRCA2相关转移性乳腺癌患者的单一药剂：加州癌症联盟审判NCT01149083
2. BRCA1 BRCA1 ‐ and BRCA2 BRCA2 ‐specific in silico tools for variant interpretation in the CAGI 5 ENIGMA challenge [J] . Padilla Natàlia, Moles‐Fernández Alejandro, Riera Casandra, Human mutation . 2019,第9期

机译：BRCA1 BRCA1 - 和BRCA2 BRCA2 - 在CAGI 5谜中挑战中的变体解释的Silico工具中的特异性
3. Incorporation of semi‐quantitative analysis of splicing alterations for the clinical interpretation of variants in BRCA1 BRCA1 and BRCA2 BRCA2 genes [J] . Montalban Gemma, Bonache Sandra, Moles‐Fernández Alejandro, Human mutation . 2019,第12期

机译：结合BRCA1 BRCA1和BRCA2 BRCA2基因临床解释临床解释剪接改变的半定量分析
4. Efficacy of the PARP Inhibitor Veliparib with Carboplatin or as a Single Agent in Patients with Germline BRCA1- or BRCA2-Associated Metastatic Breast Cancer [O] . George Somlo, Paul H. Frankel, Banu K. Arun, -1

机译：PARP抑制剂维利帕利布与卡铂或作为单一药物在生殖细胞BRCA1或BRCA2相关的转移性乳腺癌患者中的疗效
5. BRCA variant classification of ClinVar submitter content from ENIGMA, ARUP laboratories and German cancer consortium compared to MH BRCA® and correlation with response to PARP inhibition in MH GUIDE® [O] . K. Stecker, U. Schmidt-Edelkraut, J. El Hokayem, 2020

机译：BRCA在MHBRCA®和响应PARP抑制中的相关性Clinvar提交者内容的Clinvar提交者内容的分类，与MHBRCA®和PARP抑制中的相关性
6. Functional Analysis of Variants of Unknown Significance in BRCA1 and BRCA2 Using Complementation of a Synthetic Lethal Interaction with PARP Inhibition. [R] . Nussbaum, R. L. 2014

机译：BRCa1和BRCa2中未知显着性变异的功能分析与paRp抑制的合成致死相互作用的互补。

Consolidated BRCA1/2 Variant Interpretation by MH BRCA Correlates with Predicted PARP Inhibitor Efficacy Association by MH Guide

著录项

相似文献

相关主题

期刊订阅